Haematex introduces Direct Oral Anticoagulant “dots”
Haematex has introduced Direct Oral Anticoagulants (DOACs) in the form of rapidlydissolving 500 nanogram “dots” on disposable plastic strips. They are stabilized in a thin, flexible film supported on a clear, inert backing. The film dissolves within 2 minutes in 1 ml of fluids such as blood, plasma or urine, thereby transferring the compound into samples. The effect of such inhibitors on individual plasmas can then be assessed using clotting or chromogenic tests.
The new supported film technology is adaptable to any potent, stable agent. It allows a library of compounds to be held as a flat collection rather than in vials, thereby allowing for more easy transport and storage.
Dabigatran-like, edoxaban-like, betrixabanlike, rivaroxaban-like and apixaban-like compounds are available. Heparin (0.3 Iu) is also available. All “dots” are colour-coded for recognition. They are especially useful for checking the effect of DOAC-extracting agents such as DOAC Stop™. They are also available in smaller sizes and in mini-tubes.
For more information, email: info@haematex.com or visit: www.haematex.com
Supplier: Haematex Research Pty Ltd
Website: http://haematex.com/
